,x,y,v,Subtypes,colors
0,0,0,LFIC0: Lipoaffinity index_3 distriCution of 0.00C,Solubility lipoaffinity,#D1963A
1,0,1,DPRC0: Distribution of 0.00C,Transcript related,#CCB441
2,0,2,PHBB0: Potential Hydrogen Bonds_3 distribution of 0.00B,Hydrogen bond related,#FFC000
3,0,3,DPRG0: Distribution of 0.00G,Transcript related,#CCB441
4,0,4,HPCB0: Gas-hexadecane PC distribution of 0.00B,Partition coefficient,#C6CEBA
5,0,5,SHAC0: Strong H-Bond acceptors_3 distriCution of 0.00C,Hydrogen bond related,#FFC000
6,0,6,PSNA0: Primary or secondary nitrogens distribution of 0.00A,Topological indice,#B4B044
7,0,7,TPSC0: Topological polar surface area_3 distriCution of 0.00C,Topological indice,#B4B044
8,0,8,SHDB0: Strong H-Bond donors distribution of 0.00B,Hydrogen bond related,#FFC000
9,0,9,PHBC0: Potential Hydrogen Bonds_3 distriCution of 0.00C,Hydrogen bond related,#FFC000
10,0,10,DPRA0: Distribution of 0.00A,Transcript related,#CCB441
11,0,11,PHBA0: Potential Hydrogen Bonds_3 distribution of 0.00A,Hydrogen bond related,#FFC000
12,0,12,LFIB0: Lipoaffinity index_3 distribution of 0.00B,Solubility lipoaffinity,#D1963A
13,0,13,SLFB0: Sum of path lengths starting from oxygens_3 distribution of 0.00B,Topological indice,#B4B044
14,0,14,SHAB0: Strong H-Bond acceptors_3 distribution of 0.00B,Hydrogen bond related,#FFC000
15,0,15,LFIB0: Lipoaffinity index distribution of 0.00B,Solubility lipoaffinity,#D1963A
16,0,16,MLFA0: Linear free energy distribution of 0.00A,Hydrogen bond related,#FFC000
17,0,17,HPCC0: Gas-hexadecane PC_3 distriCution of 0.00C,Partition coefficient,#C6CEBA
18,0,18,DPRT1: Distribution of 0.25T,Transcript related,#CCB441
19,0,19,TPSB1: Topological polar surface area_3 distribution of 0.25B,Topological indice,#B4B044
20,0,20,SLFC1: Sum of path lengths starting from oxygens_3 distriCution of 0.25C,Topological indice,#B4B044
21,0,21,DPRA2: Distribution of 0.50A,Transcript related,#CCB441
22,0,22,SHAB1: Strong H-Bond acceptors_3 distribution of 0.25B,Hydrogen bond related,#FFC000
23,0,23,LFIB1: Lipoaffinity index distribution of 0.25B,Solubility lipoaffinity,#D1963A
24,0,24,LFIB1: Lipoaffinity index_3 distribution of 0.25B,Solubility lipoaffinity,#D1963A
25,0,25,DPRA1: Distribution of 0.25A,Transcript related,#CCB441
26,0,26,HPCB1: Gas-hexadecane PC_3 distribution of 0.25B,Partition coefficient,#C6CEBA
27,0,27,PHBB1: Potential Hydrogen Bonds_3 distribution of 0.25B,Hydrogen bond related,#FFC000
28,1,0,LFI: Lipoaffinity index_3110,Solubility lipoaffinity,#D1963A
29,1,1,MLF: Linear free energy000,Hydrogen bond related,#FFC000
30,1,2,PHB: Potential Hydrogen Bonds_3000,Hydrogen bond related,#FFC000
31,1,3,MLF: Linear free energy00,Hydrogen bond related,#FFC000
32,1,4,TraAT: Transition between A and T,Transcript related,#CCB441
33,1,5,HPC: Gas-hexadecane PC_3220,Partition coefficient,#C6CEBA
34,1,6,HPC: Gas-hexadecane PC_3022,Partition coefficient,#C6CEBA
35,1,7,SCDGG: Series correlation PseDN composition of GG,Nucleotide related,#ED7D31
36,1,8,PSN: Primary or secondary nitrogens011,Topological indice,#B4B044
37,1,9,PSN: Primary or secondary nitrogens110,Topological indice,#B4B044
38,1,10,HPCB0: Gas-hexadecane PC_3 distribution of 0.00B,Partition coefficient,#C6CEBA
39,1,11,DPRT0: Distribution of 0.00T,Transcript related,#CCB441
40,1,12,PSNB0: Primary or secondary nitrogens distribution of 0.00B,Topological indice,#B4B044
41,1,13,SLFC0: Sum of path lengths starting from oxygens_3 distriCution of 0.00C,Topological indice,#B4B044
42,1,14,TPSB0: Topological polar surface area_3 distribution of 0.00B,Topological indice,#B4B044
43,1,15,HPCC2: Gas-hexadecane PC_3 distriCution of 0.50C,Partition coefficient,#C6CEBA
44,1,16,DPRT2: Distribution of 0.50T,Transcript related,#CCB441
45,1,17,SLFC2: Sum of path lengths starting from oxygens_3 distriCution of 0.50C,Topological indice,#B4B044
46,1,18,PSNB1: Primary or secondary nitrogens distribution of 0.25B,Topological indice,#B4B044
47,1,19,HPCC1: Gas-hexadecane PC_3 distriCution of 0.25C,Partition coefficient,#C6CEBA
48,1,20,SLFB2: Sum of path lengths starting from oxygens_3 distribution of 0.50B,Topological indice,#B4B044
49,1,21,LFIB2: Lipoaffinity index_3 distribution of 0.50B,Solubility lipoaffinity,#D1963A
50,1,22,SHAB2: Strong H-Bond acceptors_3 distribution of 0.50B,Hydrogen bond related,#FFC000
51,1,23,LFIB2: Lipoaffinity index distribution of 0.50B,Solubility lipoaffinity,#D1963A
52,1,24,SLFB1: Sum of path lengths starting from oxygens_3 distribution of 0.25B,Topological indice,#B4B044
53,1,25,DPRC1: Distribution of 0.25C,Transcript related,#CCB441
54,1,26,HPCB1: Gas-hexadecane PC distribution of 0.25B,Partition coefficient,#C6CEBA
55,1,27,SHAC1: Strong H-Bond acceptors_3 distriCution of 0.25C,Hydrogen bond related,#FFC000
56,2,0,LFI: Lipoaffinity index_3011,Solubility lipoaffinity,#D1963A
57,2,1,PHB: Potential Hydrogen Bonds_300,Hydrogen bond related,#FFC000
58,2,2,PCDAG: Parallel correlation PseDN composition of AG,Nucleotide related,#ED7D31
59,2,3,SLFBC: Sum of path lengths starting from oxygens_3 transition between B and C,Topological indice,#B4B044
60,2,4,TraEY: Entropy density Y on transcript,Transcript related,#CCB441
61,2,5,PCDGA: Parallel correlation PseDN composition of GA,Nucleotide related,#ED7D31
62,2,6,TPS: Topological polar surface area_3011,Topological indice,#B4B044
63,2,7,PCDGG: Parallel correlation PseDN composition of GG,Nucleotide related,#ED7D31
64,2,8,TraEF: Entropy density F on transcript,Transcript related,#CCB441
65,2,9,SLF: Sum of path lengths starting from oxygens_3220,Topological indice,#B4B044
66,2,10,SLF: Sum of path lengths starting from oxygens_3022,Topological indice,#B4B044
67,2,11,PSNCB: Primary or secondary nitrogens composition of B,Topological indice,#B4B044
68,2,12,ComRT: Composition of T,Transcript related,#CCB441
69,2,13,C3UTR: Coverage of 3 untranslated region,Transcript related,#CCB441
70,2,14,ORFIn: ORF integrity,Open reading frame,#BDC6CF
71,2,15,PSNB3: Primary or secondary nitrogens distribution of 0.75B,Topological indice,#B4B044
72,2,16,SLFC3: Sum of path lengths starting from oxygens_3 distriCution of 0.75C,Topological indice,#B4B044
73,2,17,TPSB2: Topological polar surface area_3 distribution of 0.50B,Topological indice,#B4B044
74,2,18,PSNB2: Primary or secondary nitrogens distribution of 0.50B,Topological indice,#B4B044
75,2,19,MLFA2: Linear free energy distribution of 0.50A,Hydrogen bond related,#FFC000
76,2,20,MLFA1: Linear free energy distribution of 0.25A,Hydrogen bond related,#FFC000
77,2,21,SLFB3: Sum of path lengths starting from oxygens_3 distribution of 0.75B,Topological indice,#B4B044
78,2,22,SHAB3: Strong H-Bond acceptors_3 distribution of 0.75B,Hydrogen bond related,#FFC000
79,2,23,DPRA3: Distribution of 0.75A,Transcript related,#CCB441
80,2,24,HPCB3: Gas-hexadecane PC_3 distribution of 0.75B,Partition coefficient,#C6CEBA
81,2,25,DPRC3: Distribution of 0.75C,Transcript related,#CCB441
82,2,26,HPCB2: Gas-hexadecane PC distribution of 0.50B,Partition coefficient,#C6CEBA
83,2,27,SHAC2: Strong H-Bond acceptors_3 distriCution of 0.50C,Hydrogen bond related,#FFC000
84,3,0,SLF: Sum of path lengths starting from oxygens_3011,Topological indice,#B4B044
85,3,1,SHA: Strong H-Bond acceptors_3011,Hydrogen bond related,#FFC000
86,3,2,TraEI: Entropy density I on transcript,Transcript related,#CCB441
87,3,3,SCDAG: Series correlation PseDN composition of AG,Nucleotide related,#ED7D31
88,3,4,SCDGA: Series correlation PseDN composition of GA,Nucleotide related,#ED7D31
89,3,5,SLF: Sum of path lengths starting from oxygens_3210,Topological indice,#B4B044
90,3,6,SLF: Sum of path lengths starting from oxygens_3021,Topological indice,#B4B044
91,3,7,TPS: Topological polar surface area_3110,Topological indice,#B4B044
92,3,8,HPC: Gas-hexadecane PC_3202,Partition coefficient,#C6CEBA
93,3,9,SLFCC: Sum of path lengths starting from oxygens_3 composition of C,Topological indice,#B4B044
94,3,10,TPS: Topological polar surface area_3101,Topological indice,#B4B044
95,3,11,TPSCB: Topological polar surface area_3 composition of B,Topological indice,#B4B044
96,3,12,SLF: Sum of path lengths starting from oxygens_3202,Topological indice,#B4B044
97,3,13,CNH: NH- count111,Molecular fingerprint,#9AB6D1
98,3,14,SHA: Strong H-Bond acceptors_300,Hydrogen bond related,#FFC000
99,3,15,DPRT3: Distribution of 0.75T,Transcript related,#CCB441
100,3,16,TPSB3: Topological polar surface area_3 distribution of 0.75B,Topological indice,#B4B044
101,3,17,HPCC3: Gas-hexadecane PC_3 distriCution of 0.75C,Partition coefficient,#C6CEBA
102,3,18,PHBA3: Potential Hydrogen Bonds_3 distribution of 0.75A,Hydrogen bond related,#FFC000
103,3,19,PHBA2: Potential Hydrogen Bonds_3 distribution of 0.50A,Hydrogen bond related,#FFC000
104,3,20,MLFA3: Linear free energy distribution of 0.75A,Hydrogen bond related,#FFC000
105,3,21,PHBA1: Potential Hydrogen Bonds_3 distribution of 0.25A,Hydrogen bond related,#FFC000
106,3,22,LFIB3: Lipoaffinity index_3 distribution of 0.75B,Solubility lipoaffinity,#D1963A
107,3,23,LFIB3: Lipoaffinity index distribution of 0.75B,Solubility lipoaffinity,#D1963A
108,3,24,PHBB3: Potential Hydrogen Bonds_3 distribution of 0.75B,Hydrogen bond related,#FFC000
109,3,25,HPCB3: Gas-hexadecane PC distribution of 0.75B,Partition coefficient,#C6CEBA
110,3,26,PHBB2: Potential Hydrogen Bonds_3 distribution of 0.50B,Hydrogen bond related,#FFC000
111,3,27,DPRC2: Distribution of 0.50C,Transcript related,#CCB441
112,4,0,SCDAA: Series correlation PseDN composition of AA,Nucleotide related,#ED7D31
113,4,1,LFI: Lipoaffinity index011,Solubility lipoaffinity,#D1963A
114,4,2,TraEN: Entropy density N on transcript,Transcript related,#CCB441
115,4,3,LFI: Lipoaffinity index_3101,Solubility lipoaffinity,#D1963A
116,4,4,LFI: Lipoaffinity index_310,Solubility lipoaffinity,#D1963A
117,4,5,HPC: Gas-hexadecane PC_302,Partition coefficient,#C6CEBA
118,4,6,HPC: Gas-hexadecane PC_3020,Partition coefficient,#C6CEBA
119,4,7,HPCAC: Gas-hexadecane PC_3 transition between A and C,Partition coefficient,#C6CEBA
120,4,8,HPC: Gas-hexadecane PC_320,Partition coefficient,#C6CEBA
121,4,9,PSN: Primary or secondary nitrogens101,Topological indice,#B4B044
122,4,10,HPCCC: Gas-hexadecane PC_3 composition of C,Partition coefficient,#C6CEBA
123,4,11,ORFEF: Entropy density F on ORF,Open reading frame,#BDC6CF
124,4,12,TraEV: Entropy density V on transcript,Transcript related,#CCB441
125,4,13,SHA: Strong H-Bond acceptors_3000,Hydrogen bond related,#FFC000
126,4,14,CNH: NH- count11,Molecular fingerprint,#9AB6D1
127,4,15,CNHCB: NH- count composition of B,Molecular fingerprint,#9AB6D1
128,4,16,SHAA2: Strong H-Bond acceptors_3 distribution of 0.50A,Hydrogen bond related,#FFC000
129,4,17,CNHB2: NH- count distribution of 0.50B,Molecular fingerprint,#9AB6D1
130,4,18,SHAA3: Strong H-Bond acceptors_3 distribution of 0.75A,Hydrogen bond related,#FFC000
131,4,19,MReB2: Molar refractivity distribution of 0.50B,Polarizability refractivity,#A0CF6D
132,4,20,HPCA2: Gas-hexadecane PC distribution of 0.50A,Partition coefficient,#C6CEBA
133,4,21,HPCA1: Gas-hexadecane PC distribution of 0.25A,Partition coefficient,#C6CEBA
134,4,22,HPCA2: Gas-hexadecane PC_3 distribution of 0.50A,Partition coefficient,#C6CEBA
135,4,23,HPCA1: Gas-hexadecane PC_3 distribution of 0.25A,Partition coefficient,#C6CEBA
136,4,24,SLFA3: Sum of path lengths starting from oxygens_3 distribution of 0.75A,Topological indice,#B4B044
137,4,25,SHAC3: Strong H-Bond acceptors_3 distriCution of 0.75C,Hydrogen bond related,#FFC000
138,4,26,MLFB1: Linear free energy distribution of 0.25B,Hydrogen bond related,#FFC000
139,4,27,HPCB2: Gas-hexadecane PC_3 distribution of 0.50B,Partition coefficient,#C6CEBA
140,5,0,LFI: Lipoaffinity index110,Solubility lipoaffinity,#D1963A
141,5,1,SHA: Strong H-Bond acceptors_3110,Hydrogen bond related,#FFC000
142,5,2,SLF: Sum of path lengths starting from oxygens_3110,Topological indice,#B4B044
143,5,3,MLF: Linear free energy001,Hydrogen bond related,#FFC000
144,5,4,LFIAB: Lipoaffinity index_3 transition between A and B,Solubility lipoaffinity,#D1963A
145,5,5,ORFEI: Entropy density I on ORF,Open reading frame,#BDC6CF
146,5,6,LFI: Lipoaffinity index_301,Solubility lipoaffinity,#D1963A
147,5,7,LFI: Lipoaffinity index_3010,Solubility lipoaffinity,#D1963A
148,5,8,ORFEY: Entropy density Y on ORF,Open reading frame,#BDC6CF
149,5,9,TPS: Topological polar surface area_310,Topological indice,#B4B044
150,5,10,TPSAB: Topological polar surface area_3 transition between A and B,Topological indice,#B4B044
151,5,11,PSN: Primary or secondary nitrogens01,Topological indice,#B4B044
152,5,12,PCDCG: Parallel correlation PseDN composition of CG,Nucleotide related,#ED7D31
153,5,13,TraTG: Transition between T and G,Transcript related,#CCB441
154,5,14,SHACA: Strong H-Bond acceptors_3 composition of A,Hydrogen bond related,#FFC000
155,5,15,SHA: Strong H-Bond acceptors_30,Hydrogen bond related,#FFC000
156,5,16,CNHB1: NH- count distribution of 0.25B,Molecular fingerprint,#9AB6D1
157,5,17,SHAA1: Strong H-Bond acceptors_3 distribution of 0.25A,Hydrogen bond related,#FFC000
158,5,18,MReB3: Molar refractivity distribution of 0.75B,Polarizability refractivity,#A0CF6D
159,5,19,LFIA1: Lipoaffinity index_3 distribution of 0.25A,Solubility lipoaffinity,#D1963A
160,5,20,LFIA2: Lipoaffinity index_3 distribution of 0.50A,Solubility lipoaffinity,#D1963A
161,5,21,HPCA3: Gas-hexadecane PC distribution of 0.75A,Partition coefficient,#C6CEBA
162,5,22,MReA3: Molar refractivity distribution of 0.75A,Polarizability refractivity,#A0CF6D
163,5,23,MReA1: Molar refractivity distribution of 0.25A,Polarizability refractivity,#A0CF6D
164,5,24,MLFB3: Linear free energy distribution of 0.75B,Hydrogen bond related,#FFC000
165,5,25,MLFB2: Linear free energy distribution of 0.50B,Hydrogen bond related,#FFC000
166,5,26,SLFA1: Sum of path lengths starting from oxygens_3 distribution of 0.25A,Topological indice,#B4B044
167,5,27,DPRG1: Distribution of 0.25G,Transcript related,#CCB441
168,6,0,TraEK: Entropy density K on transcript,Transcript related,#CCB441
169,6,1,ORFEK: Entropy density K on ORF,Open reading frame,#BDC6CF
170,6,2,LFICB: Lipoaffinity index composition of B,Solubility lipoaffinity,#D1963A
171,6,3,LFI: Lipoaffinity index101,Solubility lipoaffinity,#D1963A
172,6,4,MLF: Linear free energy100,Hydrogen bond related,#FFC000
173,6,5,MLF: Linear free energy0,Hydrogen bond related,#FFC000
174,6,6,PHBCA: Potential Hydrogen Bonds_3 composition of A,Hydrogen bond related,#FFC000
175,6,7,LFI: Lipoaffinity index_3100,Solubility lipoaffinity,#D1963A
176,6,8,SHD: Strong H-Bond donors000,Hydrogen bond related,#FFC000
177,6,9,TPS: Topological polar surface area_3010,Topological indice,#B4B044
178,6,10,TPS: Topological polar surface area_301,Topological indice,#B4B044
179,6,11,PSNAB: Primary or secondary nitrogens transition between A and B,Topological indice,#B4B044
180,6,12,SCDCG: Series correlation PseDN composition of CG,Nucleotide related,#ED7D31
181,6,13,TPSBC: Topological polar surface area_3 transition between B and C,Topological indice,#B4B044
182,6,14,CNH: NH- count1,Molecular fingerprint,#9AB6D1
183,6,15,CNH: NH- count011,Molecular fingerprint,#9AB6D1
184,6,16,CNHB3: NH- count distribution of 0.75B,Molecular fingerprint,#9AB6D1
185,6,17,LFIA1: Lipoaffinity index distribution of 0.25A,Solubility lipoaffinity,#D1963A
186,6,18,LFIA3: Lipoaffinity index_3 distribution of 0.75A,Solubility lipoaffinity,#D1963A
187,6,19,MReB1: Molar refractivity distribution of 0.25B,Polarizability refractivity,#A0CF6D
188,6,20,SHDA1: Strong H-Bond donors distribution of 0.25A,Hydrogen bond related,#FFC000
189,6,21,SHDA2: Strong H-Bond donors distribution of 0.50A,Hydrogen bond related,#FFC000
190,6,22,HPCA3: Gas-hexadecane PC_3 distribution of 0.75A,Partition coefficient,#C6CEBA
191,6,23,MReA2: Molar refractivity distribution of 0.50A,Polarizability refractivity,#A0CF6D
192,6,24,PSNA2: Primary or secondary nitrogens distribution of 0.50A,Topological indice,#B4B044
193,6,25,SLFA2: Sum of path lengths starting from oxygens_3 distribution of 0.50A,Topological indice,#B4B044
194,6,26,LFIC2: Lipoaffinity index_3 distriCution of 0.50C,Solubility lipoaffinity,#D1963A
195,6,27,PHBC1: Potential Hydrogen Bonds_3 distriCution of 0.25C,Hydrogen bond related,#FFC000
196,7,0,PCDAA: Parallel correlation PseDN composition of AA,Nucleotide related,#ED7D31
197,7,1,SHACB: Strong H-Bond acceptors_3 composition of B,Hydrogen bond related,#FFC000
198,7,2,SHA: Strong H-Bond acceptors_3101,Hydrogen bond related,#FFC000
199,7,3,PHB: Potential Hydrogen Bonds_3002,Hydrogen bond related,#FFC000
200,7,4,PHB: Potential Hydrogen Bonds_30,Hydrogen bond related,#FFC000
201,7,5,MLFCA: Linear free energy composition of A,Hydrogen bond related,#FFC000
202,7,6,PHB: Potential Hydrogen Bonds_3001,Hydrogen bond related,#FFC000
203,7,7,PHB: Potential Hydrogen Bonds_3100,Hydrogen bond related,#FFC000
204,7,8,TPS: Topological polar surface area_3100,Topological indice,#B4B044
205,7,9,TPS: Topological polar surface area_3001,Topological indice,#B4B044
206,7,10,PSN: Primary or secondary nitrogens10,Topological indice,#B4B044
207,7,11,TPS: Topological polar surface area_3210,Topological indice,#B4B044
208,7,12,ORFEC: Entropy density C on ORF,Open reading frame,#BDC6CF
209,7,13,PCDGC: Parallel correlation PseDN composition of GC,Nucleotide related,#ED7D31
210,7,14,ORFEV: Entropy density V on ORF,Open reading frame,#BDC6CF
211,7,15,HPCC4: Gas-hexadecane PC_3 distriCution of 1.00C,Partition coefficient,#C6CEBA
212,7,16,PSNB4: Primary or secondary nitrogens distribution of 1.00B,Topological indice,#B4B044
213,7,17,LFIA4: Lipoaffinity index_3 distribution of 1.00A,Solubility lipoaffinity,#D1963A
214,7,18,LFIA3: Lipoaffinity index distribution of 0.75A,Solubility lipoaffinity,#D1963A
215,7,19,LFIA2: Lipoaffinity index distribution of 0.50A,Solubility lipoaffinity,#D1963A
216,7,20,MLFA4: Linear free energy distribution of 1.00A,Hydrogen bond related,#FFC000
217,7,21,MReA4: Molar refractivity distribution of 1.00A,Polarizability refractivity,#A0CF6D
218,7,22,SHDA3: Strong H-Bond donors distribution of 0.75A,Hydrogen bond related,#FFC000
219,7,23,PSNA3: Primary or secondary nitrogens distribution of 0.75A,Topological indice,#B4B044
220,7,24,PSNA1: Primary or secondary nitrogens distribution of 0.25A,Topological indice,#B4B044
221,7,25,C5UTR: Coverage of 5 untranslated region,Transcript related,#CCB441
222,7,26,TPSC2: Topological polar surface area_3 distriCution of 0.50C,Topological indice,#B4B044
223,7,27,TPSC1: Topological polar surface area_3 distriCution of 0.25C,Topological indice,#B4B044
224,8,0,SLFCB: Sum of path lengths starting from oxygens_3 composition of B,Topological indice,#B4B044
225,8,1,ComRA: Composition of A,Transcript related,#CCB441
226,8,2,ORFEN: Entropy density N on ORF,Open reading frame,#BDC6CF
227,8,3,PHB: Potential Hydrogen Bonds_3200,Hydrogen bond related,#FFC000
228,8,4,HPC: Gas-hexadecane PC000,Partition coefficient,#C6CEBA
229,8,5,HPC: Gas-hexadecane PC_3002,Partition coefficient,#C6CEBA
230,8,6,SLF: Sum of path lengths starting from oxygens_3012,Topological indice,#B4B044
231,8,7,TraEM: Entropy density M on transcript,Transcript related,#CCB441
232,8,8,LFI: Lipoaffinity index_3001,Solubility lipoaffinity,#D1963A
233,8,9,SHD: Strong H-Bond donors00,Hydrogen bond related,#FFC000
234,8,10,PSN: Primary or secondary nitrogens010,Topological indice,#B4B044
235,8,11,TPS: Topological polar surface area_3021,Topological indice,#B4B044
236,8,12,TraEC: Entropy density C on transcript,Transcript related,#CCB441
237,8,13,ORFEW: Entropy density W on ORF,Open reading frame,#BDC6CF
238,8,14,CNH: NH- count110,Molecular fingerprint,#9AB6D1
239,8,15,SLFC4: Sum of path lengths starting from oxygens_3 distriCution of 1.00C,Topological indice,#B4B044
240,8,16,TPSB4: Topological polar surface area_3 distribution of 1.00B,Topological indice,#B4B044
241,8,17,SHAA4: Strong H-Bond acceptors_3 distribution of 1.00A,Hydrogen bond related,#FFC000
242,8,18,CNHB4: NH- count distribution of 1.00B,Molecular fingerprint,#9AB6D1
243,8,19,LFIA4: Lipoaffinity index distribution of 1.00A,Solubility lipoaffinity,#D1963A
244,8,20,SHDA4: Strong H-Bond donors distribution of 1.00A,Hydrogen bond related,#FFC000
245,8,21,CNHA4: NH- count distribution of 1.00A,Molecular fingerprint,#9AB6D1
246,8,22,HPCA4: Gas-hexadecane PC distribution of 1.00A,Partition coefficient,#C6CEBA
247,8,23,CNHA3: NH- count distribution of 0.75A,Molecular fingerprint,#9AB6D1
248,8,24,TPSA2: Topological polar surface area_3 distribution of 0.50A,Topological indice,#B4B044
249,8,25,PHBC3: Potential Hydrogen Bonds_3 distriCution of 0.75C,Hydrogen bond related,#FFC000
250,8,26,PHBC2: Potential Hydrogen Bonds_3 distriCution of 0.50C,Hydrogen bond related,#FFC000
251,8,27,SHDB1: Strong H-Bond donors distribution of 0.25B,Hydrogen bond related,#FFC000
252,9,0,CC218: Cross covariance of lag2 on SKE-ETI,Nucleotide related,#ED7D31
253,9,1,SLF: Sum of path lengths starting from oxygens_3101,Topological indice,#B4B044
254,9,2,LFICB: Lipoaffinity index_3 composition of B,Solubility lipoaffinity,#D1963A
255,9,3,SHA: Strong H-Bond acceptors_301,Hydrogen bond related,#FFC000
256,9,4,SHAAB: Strong H-Bond acceptors_3 transition between A and B,Hydrogen bond related,#FFC000
257,9,5,SHA: Strong H-Bond acceptors_3100,Hydrogen bond related,#FFC000
258,9,6,SLF: Sum of path lengths starting from oxygens_3120,Topological indice,#B4B044
259,9,7,SLF: Sum of path lengths starting from oxygens_3102,Topological indice,#B4B044
260,9,8,PHB: Potential Hydrogen Bonds_3010,Hydrogen bond related,#FFC000
261,9,9,SHDCA: Strong H-Bond donors composition of A,Hydrogen bond related,#FFC000
262,9,10,PSN: Primary or secondary nitrogens100,Topological indice,#B4B044
263,9,11,SCDGC: Series correlation PseDN composition of GC,Nucleotide related,#ED7D31
264,9,12,TPS: Topological polar surface area_3120,Topological indice,#B4B044
265,9,13,TPS: Topological polar surface area_3012,Topological indice,#B4B044
266,9,14,ORFEL: Entropy density L on ORF,Open reading frame,#BDC6CF
267,9,15,DPRT4: Distribution of 1.00T,Transcript related,#CCB441
268,9,16,PCDl1: Parallel correlation PseDN composition of lamda1,Nucleotide related,#ED7D31
269,9,17,MReB4: Molar refractivity distribution of 1.00B,Polarizability refractivity,#A0CF6D
270,9,18,MLFB4: Linear free energy distribution of 1.00B,Hydrogen bond related,#FFC000
271,9,19,SLFA4: Sum of path lengths starting from oxygens_3 distribution of 1.00A,Topological indice,#B4B044
272,9,20,HPCA4: Gas-hexadecane PC_3 distribution of 1.00A,Partition coefficient,#C6CEBA
273,9,21,PSNA4: Primary or secondary nitrogens distribution of 1.00A,Topological indice,#B4B044
274,9,22,PHBA4: Potential Hydrogen Bonds_3 distribution of 1.00A,Hydrogen bond related,#FFC000
275,9,23,TPSA3: Topological polar surface area_3 distribution of 0.75A,Topological indice,#B4B044
276,9,24,CNHA2: NH- count distribution of 0.50A,Molecular fingerprint,#9AB6D1
277,9,25,DPRG3: Distribution of 0.75G,Transcript related,#CCB441
278,9,26,TPSC3: Topological polar surface area_3 distriCution of 0.75C,Topological indice,#B4B044
279,9,27,LFIC1: Lipoaffinity index_3 distriCution of 0.25C,Solubility lipoaffinity,#D1963A
280,10,0,CC219: Cross covariance of lag2 on SKE-WCI,Nucleotide related,#ED7D31
281,10,1,APTW2: Dinucleotide auto covariance of lag2 on PTW,Nucleotide related,#ED7D31
282,10,2,ASTB1: Dinucleotide auto covariance of lag1 on STB,Nucleotide related,#ED7D31
283,10,3,SHA: Strong H-Bond acceptors_310,Hydrogen bond related,#FFC000
284,10,4,SHA: Strong H-Bond acceptors_3010,Hydrogen bond related,#FFC000
285,10,5,SHA: Strong H-Bond acceptors_3001,Hydrogen bond related,#FFC000
286,10,6,HPC: Gas-hexadecane PC00,Partition coefficient,#C6CEBA
287,10,7,SLF: Sum of path lengths starting from oxygens_3201,Topological indice,#B4B044
288,10,8,HPC: Gas-hexadecane PC_3200,Partition coefficient,#C6CEBA
289,10,9,SHD: Strong H-Bond donors0,Hydrogen bond related,#FFC000
290,10,10,PSN: Primary or secondary nitrogens001,Topological indice,#B4B044
291,10,11,SLF: Sum of path lengths starting from oxygens_320,Topological indice,#B4B044
292,10,12,SLFAC: Sum of path lengths starting from oxygens_3 transition between A and C,Topological indice,#B4B044
293,10,13,ProAH: Pseudo protein average hydropathy,Pseudo protein related,#B3CE93
294,10,14,TraES: Entropy density S on transcript,Transcript related,#CCB441
295,10,15,MRe: Molar refractivity011,Polarizability refractivity,#A0CF6D
296,10,16,ORFES: Entropy density S on ORF,Open reading frame,#BDC6CF
297,10,17,PCDl2: Parallel correlation PseDN composition of lamda2,Nucleotide related,#ED7D31
298,10,18,(,Secondary structure,#76A6D3
299,10,19,(((,Secondary structure,#76A6D3
300,10,20,TPSA4: Topological polar surface area_3 distribution of 1.00A,Topological indice,#B4B044
301,10,21,ProPI: Pseudo protein isoelectric point,Pseudo protein related,#B3CE93
302,10,22,LFIB4: Lipoaffinity index_3 distribution of 1.00B,Solubility lipoaffinity,#D1963A
303,10,23,SLFB4: Sum of path lengths starting from oxygens_3 distribution of 1.00B,Topological indice,#B4B044
304,10,24,CNHA1: NH- count distribution of 0.25A,Molecular fingerprint,#9AB6D1
305,10,25,TPSA1: Topological polar surface area_3 distribution of 0.25A,Topological indice,#B4B044
306,10,26,LFIC3: Lipoaffinity index_3 distriCution of 0.75C,Solubility lipoaffinity,#D1963A
307,10,27,DPRG2: Distribution of 0.50G,Transcript related,#CCB441
308,11,0,CC217: Cross covariance of lag2 on SKE-BDS,Nucleotide related,#ED7D31
309,11,1,AETI2: Dinucleotide auto covariance of lag2 on ETI,Nucleotide related,#ED7D31
310,11,2,ABST1: Dinucleotide auto covariance of lag1 on BST,Nucleotide related,#ED7D31
311,11,3,AROL1: Dinucleotide auto covariance of lag1 on ROL,Nucleotide related,#ED7D31
312,11,4,LFI: Lipoaffinity index10,Solubility lipoaffinity,#D1963A
313,11,5,LFI: Lipoaffinity index01,Solubility lipoaffinity,#D1963A
314,11,6,PHB: Potential Hydrogen Bonds_3020,Hydrogen bond related,#FFC000
315,11,7,MLF: Linear free energy010,Hydrogen bond related,#FFC000
316,11,8,HPC: Gas-hexadecane PC0,Partition coefficient,#C6CEBA
317,11,9,ORFEM: Entropy density M on ORF,Open reading frame,#BDC6CF
318,11,10,HPC: Gas-hexadecane PC_3201,Partition coefficient,#C6CEBA
319,11,11,SLF: Sum of path lengths starting from oxygens_302,Topological indice,#B4B044
320,11,12,LFICA: Lipoaffinity index_3 composition of A,Solubility lipoaffinity,#D1963A
321,11,13,TraEL: Entropy density L on transcript,Transcript related,#CCB441
322,11,14,MRe: Molar refractivity1,Polarizability refractivity,#A0CF6D
323,11,15,LFI: Lipoaffinity index0,Solubility lipoaffinity,#D1963A
324,11,16,HPCB4: Gas-hexadecane PC_3 distribution of 1.00B,Partition coefficient,#C6CEBA
325,11,17,SHAC4: Strong H-Bond acceptors_3 distriCution of 1.00C,Hydrogen bond related,#FFC000
326,11,18,((,Secondary structure,#76A6D3
327,11,19,((((,Secondary structure,#76A6D3
328,11,20,TPSC4: Topological polar surface area_3 distriCution of 1.00C,Topological indice,#B4B044
329,11,21,SHDB4: Strong H-Bond donors distribution of 1.00B,Hydrogen bond related,#FFC000
330,11,22,LFIB4: Lipoaffinity index distribution of 1.00B,Solubility lipoaffinity,#D1963A
331,11,23,SHAB4: Strong H-Bond acceptors_3 distribution of 1.00B,Hydrogen bond related,#FFC000
332,11,24,DPRA4: Distribution of 1.00A,Transcript related,#CCB441
333,11,25,MRe: Molar refractivity100,Polarizability refractivity,#A0CF6D
334,11,26,SHDB3: Strong H-Bond donors distribution of 0.75B,Hydrogen bond related,#FFC000
335,11,27,SHDB2: Strong H-Bond donors distribution of 0.50B,Hydrogen bond related,#FFC000
336,12,0,ADGC2: Dinucleotide auto covariance of lag2 on DGC,Nucleotide related,#ED7D31
337,12,1,AWCI2: Dinucleotide auto covariance of lag2 on WCI,Nucleotide related,#ED7D31
338,12,2,CC213: Cross covariance of lag2 on ETI-SKE,Nucleotide related,#ED7D31
339,12,3,ASKE1: Dinucleotide auto covariance of lag1 on SKE,Nucleotide related,#ED7D31
340,12,4,L1SKE: Series correlation PseDN composition of lamda1-SKE,Nucleotide related,#ED7D31
341,12,5,nMFE,Secondary structure,#76A6D3
342,12,6,LFIAB: Lipoaffinity index transition between A and B,Solubility lipoaffinity,#D1963A
343,12,7,HPCCA: Gas-hexadecane PC composition of A,Partition coefficient,#C6CEBA
344,12,8,HPC: Gas-hexadecane PC_3102,Partition coefficient,#C6CEBA
345,12,9,MRe: Molar refractivity101,Polarizability refractivity,#A0CF6D
346,12,10,MRe: Molar refractivity10,Polarizability refractivity,#A0CF6D
347,12,11,LFI: Lipoaffinity index_300,Solubility lipoaffinity,#D1963A
348,12,12,MRe: Molar refractivity111,Polarizability refractivity,#A0CF6D
349,12,13,LFI: Lipoaffinity index_30,Solubility lipoaffinity,#D1963A
350,12,14,MReCB: Molar refractivity composition of B,Polarizability refractivity,#A0CF6D
351,12,15,LFICA: Lipoaffinity index composition of A,Solubility lipoaffinity,#D1963A
352,12,16,HPCB4: Gas-hexadecane PC distribution of 1.00B,Partition coefficient,#C6CEBA
353,12,17,LFI: Lipoaffinity index100,Solubility lipoaffinity,#D1963A
354,12,18,CNH: NH- count01,Molecular fingerprint,#9AB6D1
355,12,19,PPMFS: Pseudo protein PI-MW frame score,Pseudo protein related,#B3CE93
356,12,20,PHBC4: Potential Hydrogen Bonds_3 distriCution of 1.00C,Hydrogen bond related,#FFC000
357,12,21,LFIC4: Lipoaffinity index_3 distriCution of 1.00C,Solubility lipoaffinity,#D1963A
358,12,22,DPRG4: Distribution of 1.00G,Transcript related,#CCB441
359,12,23,MRe: Molar refractivity001,Polarizability refractivity,#A0CF6D
360,12,24,HPCCA: Gas-hexadecane PC_3 composition of A,Partition coefficient,#C6CEBA
361,12,25,HPC: Gas-hexadecane PC_30,Partition coefficient,#C6CEBA
362,12,26,MRe: Molar refractivity0,Polarizability refractivity,#A0CF6D
363,12,27,HPC: Gas-hexadecane PC_300,Partition coefficient,#C6CEBA
364,13,0,APIA2: Dinucleotide auto covariance of lag2 on PIA,Nucleotide related,#ED7D31
365,13,1,ASDG2: Dinucleotide auto covariance of lag2 on SDG,Nucleotide related,#ED7D31
366,13,2,CC224: Cross covariance of lag2 on WCI-SKE,Nucleotide related,#ED7D31
367,13,3,CC208: Cross covariance of lag2 on BDS-SKE,Nucleotide related,#ED7D31
368,13,4,ABST2: Dinucleotide auto covariance of lag2 on BST,Nucleotide related,#ED7D31
369,13,5,ADDT2: Dinucleotide auto covariance of lag2 on DDT,Nucleotide related,#ED7D31
370,13,6,ALBZ2: Dinucleotide auto covariance of lag2 on LBZ,Nucleotide related,#ED7D31
371,13,7,LFI: Lipoaffinity index_3102,Solubility lipoaffinity,#D1963A
372,13,8,CC126: Cross covariance of lag1 on SLI-PID,Nucleotide related,#ED7D31
373,13,9,CC105: Cross covariance of lag1 on PID-SLI,Nucleotide related,#ED7D31
374,13,10,MReAB: Molar refractivity transition between A and B,Polarizability refractivity,#A0CF6D
375,13,11,SCDTG: Series correlation PseDN composition of TG,Nucleotide related,#ED7D31
376,13,12,LFI: Lipoaffinity index_3000,Solubility lipoaffinity,#D1963A
377,13,13,MRe: Molar refractivity11,Polarizability refractivity,#A0CF6D
378,13,14,MRe: Molar refractivity110,Polarizability refractivity,#A0CF6D
379,13,15,PHBB4: Potential Hydrogen Bonds_3 distribution of 1.00B,Hydrogen bond related,#FFC000
380,13,16,DPRC4: Distribution of 1.00C,Transcript related,#CCB441
381,13,17,LFI: Lipoaffinity index001,Solubility lipoaffinity,#D1963A
382,13,18,CNH: NH- count101,Molecular fingerprint,#9AB6D1
383,13,19,CNH: NH- count10,Molecular fingerprint,#9AB6D1
384,13,20,CNHAB: NH- count transition between A and B,Molecular fingerprint,#9AB6D1
385,13,21,SHD: Strong H-Bond donors001,Hydrogen bond related,#FFC000
386,13,22,ORFED: Entropy density D on ORF,Open reading frame,#BDC6CF
387,13,23,PHB: Potential Hydrogen Bonds_320,Hydrogen bond related,#FFC000
388,13,24,MReCA: Molar refractivity composition of A,Polarizability refractivity,#A0CF6D
389,13,25,MRe: Molar refractivity00,Polarizability refractivity,#A0CF6D
390,13,26,HPC: Gas-hexadecane PC_3000,Partition coefficient,#C6CEBA
391,13,27,LFIBC: Lipoaffinity index_3 transition between B and C,Solubility lipoaffinity,#D1963A
392,14,0,CC113: Cross covariance of lag1 on ETI-SKE,Nucleotide related,#ED7D31
393,14,1,CC223: Cross covariance of lag2 on WCI-ETI,Nucleotide related,#ED7D31
394,14,2,ADST2: Dinucleotide auto covariance of lag2 on DST,Nucleotide related,#ED7D31
395,14,3,ASMH2: Dinucleotide auto covariance of lag2 on SMH,Nucleotide related,#ED7D31
396,14,4,ASKE2: Dinucleotide auto covariance of lag2 on SKE,Nucleotide related,#ED7D31
397,14,5,ASTB2: Dinucleotide auto covariance of lag2 on STB,Nucleotide related,#ED7D31
398,14,6,ARIS2: Dinucleotide auto covariance of lag2 on RIS,Nucleotide related,#ED7D31
399,14,7,APDT2: Dinucleotide auto covariance of lag2 on PDT,Nucleotide related,#ED7D31
400,14,8,MRe: Molar refractivity010,Polarizability refractivity,#A0CF6D
401,14,9,MRe: Molar refractivity01,Polarizability refractivity,#A0CF6D
402,14,10,TraTC: Transition between T and C,Transcript related,#CCB441
403,14,11,PCDTG: Parallel correlation PseDN composition of TG,Nucleotide related,#ED7D31
404,14,12,HPC: Gas-hexadecane PC_3012,Partition coefficient,#C6CEBA
405,14,13,SCDGT: Series correlation PseDN composition of GT,Nucleotide related,#ED7D31
406,14,14,PHB: Potential Hydrogen Bonds_310,Hydrogen bond related,#FFC000
407,14,15,LFI: Lipoaffinity index010,Solubility lipoaffinity,#D1963A
408,14,16,MLFAB: Linear free energy transition between A and B,Hydrogen bond related,#FFC000
409,14,17,MLF: Linear free energy01,Hydrogen bond related,#FFC000
410,14,18,SHA: Strong H-Bond acceptors_3201,Hydrogen bond related,#FFC000
411,14,19,TPS: Topological polar surface area_3201,Topological indice,#B4B044
412,14,20,SHD: Strong H-Bond donors100,Hydrogen bond related,#FFC000
413,14,21,PHB: Potential Hydrogen Bonds_302,Hydrogen bond related,#FFC000
414,14,22,PHBAC: Potential Hydrogen Bonds_3 transition between A and C,Hydrogen bond related,#FFC000
415,14,23,LFI: Lipoaffinity index_3021,Solubility lipoaffinity,#D1963A
416,14,24,PCDCA: Parallel correlation PseDN composition of CA,Nucleotide related,#ED7D31
417,14,25,MRe: Molar refractivity000,Polarizability refractivity,#A0CF6D
418,14,26,ORFEE: Entropy density E on ORF,Open reading frame,#BDC6CF
419,14,27,TraEE: Entropy density E on transcript,Transcript related,#CCB441
420,15,0,CC124: Cross covariance of lag1 on WCI-SKE,Nucleotide related,#ED7D31
421,15,1,CC214: Cross covariance of lag2 on ETI-WCI,Nucleotide related,#ED7D31
422,15,2,ASMG2: Dinucleotide auto covariance of lag2 on SMG,Nucleotide related,#ED7D31
423,15,3,CC222: Cross covariance of lag2 on WCI-BDS,Nucleotide related,#ED7D31
424,15,4,L2SKE: Series correlation PseDN composition of lamda2-SKE,Nucleotide related,#ED7D31
425,15,5,ASDS1: Dinucleotide auto covariance of lag1 on SDS,Nucleotide related,#ED7D31
426,15,6,AHTF2: Dinucleotide auto covariance of lag2 on HTF,Nucleotide related,#ED7D31
427,15,7,ASEZ2: Dinucleotide auto covariance of lag2 on SEZ,Nucleotide related,#ED7D31
428,15,8,ATWI2: Dinucleotide auto covariance of lag2 on TWI,Nucleotide related,#ED7D31
429,15,9,LFI: Lipoaffinity index_3201,Solubility lipoaffinity,#D1963A
430,15,10,HPC: Gas-hexadecane PC_3120,Partition coefficient,#C6CEBA
431,15,11,HPCBC: Gas-hexadecane PC_3 transition between B and C,Partition coefficient,#C6CEBA
432,15,12,PCDGT: Parallel correlation PseDN composition of GT,Nucleotide related,#ED7D31
433,15,13,PHB: Potential Hydrogen Bonds_301,Hydrogen bond related,#FFC000
434,15,14,PHBAB: Potential Hydrogen Bonds_3 transition between A and B,Hydrogen bond related,#FFC000
435,15,15,SHA: Strong H-Bond acceptors_3021,Hydrogen bond related,#FFC000
436,15,16,SHA: Strong H-Bond acceptors_3210,Hydrogen bond related,#FFC000
437,15,17,MLF: Linear free energy10,Hydrogen bond related,#FFC000
438,15,18,CNH: NH- count010,Molecular fingerprint,#9AB6D1
439,15,19,LFI: Lipoaffinity index_3012,Solubility lipoaffinity,#D1963A
440,15,20,TraED: Entropy density D on transcript,Transcript related,#CCB441
441,15,21,LFI: Lipoaffinity index_3210,Solubility lipoaffinity,#D1963A
442,15,22,SCDAC: Series correlation PseDN composition of AC,Nucleotide related,#ED7D31
443,15,23,SCDCA: Series correlation PseDN composition of CA,Nucleotide related,#ED7D31
444,15,24,PCDAC: Parallel correlation PseDN composition of AC,Nucleotide related,#ED7D31
445,15,25,TraAG: Transition between A and G,Transcript related,#CCB441
446,15,26,HPCAB: Gas-hexadecane PC transition between A and B,Partition coefficient,#C6CEBA
447,15,27,HPC: Gas-hexadecane PC10,Partition coefficient,#C6CEBA
448,16,0,TPS: Topological polar surface area_3102,Topological indice,#B4B044
449,16,1,L2ETI: Series correlation PseDN composition of lamda2-ETI,Nucleotide related,#ED7D31
450,16,2,CC209: Cross covariance of lag2 on BDS-WCI,Nucleotide related,#ED7D31
451,16,3,CC207: Cross covariance of lag2 on BDS-ETI,Nucleotide related,#ED7D31
452,16,4,ASMS2: Dinucleotide auto covariance of lag2 on SMS,Nucleotide related,#ED7D31
453,16,5,ASDH1: Dinucleotide auto covariance of lag1 on SDH,Nucleotide related,#ED7D31
454,16,6,APID2: Dinucleotide auto covariance of lag2 on PID,Nucleotide related,#ED7D31
455,16,7,L2SLI: Series correlation PseDN composition of lamda2-SLI,Nucleotide related,#ED7D31
456,16,8,L2PID: Series correlation PseDN composition of lamda2-PID,Nucleotide related,#ED7D31
457,16,9,ASLI2: Dinucleotide auto covariance of lag2 on SLI,Nucleotide related,#ED7D31
458,16,10,HPC: Gas-hexadecane PC_3021,Partition coefficient,#C6CEBA
459,16,11,HPC: Gas-hexadecane PC_3210,Partition coefficient,#C6CEBA
460,16,12,SHABC: Strong H-Bond acceptors_3 transition between B and C,Hydrogen bond related,#FFC000
461,16,13,SHA: Strong H-Bond acceptors_3012,Hydrogen bond related,#FFC000
462,16,14,PCDTA: Parallel correlation PseDN composition of TA,Nucleotide related,#ED7D31
463,16,15,SCDTA: Series correlation PseDN composition of TA,Nucleotide related,#ED7D31
464,16,16,CNH: NH- count100,Molecular fingerprint,#9AB6D1
465,16,17,SLFAB: Sum of path lengths starting from oxygens_3 transition between A and B,Topological indice,#B4B044
466,16,18,SLF: Sum of path lengths starting from oxygens_310,Topological indice,#B4B044
467,16,19,SLF: Sum of path lengths starting from oxygens_301,Topological indice,#B4B044
468,16,20,SHA: Strong H-Bond acceptors_3102,Hydrogen bond related,#FFC000
469,16,21,LFI: Lipoaffinity index_3120,Solubility lipoaffinity,#D1963A
470,16,22,HPC: Gas-hexadecane PC001,Partition coefficient,#C6CEBA
471,16,23,HPC: Gas-hexadecane PC010,Partition coefficient,#C6CEBA
472,16,24,HPC: Gas-hexadecane PC_3010,Partition coefficient,#C6CEBA
473,16,25,HPC: Gas-hexadecane PC01,Partition coefficient,#C6CEBA
474,16,26,LFI: Lipoaffinity index_3002,Solubility lipoaffinity,#D1963A
475,16,27,LFI: Lipoaffinity index00,Solubility lipoaffinity,#D1963A
476,17,0,L1WCI: Series correlation PseDN composition of lamda1-WCI,Nucleotide related,#ED7D31
477,17,1,CC108: Cross covariance of lag1 on BDS-SKE,Nucleotide related,#ED7D31
478,17,2,CC212: Cross covariance of lag2 on ETI-BDS,Nucleotide related,#ED7D31
479,17,3,ABDS2: Dinucleotide auto covariance of lag2 on BDS,Nucleotide related,#ED7D31
480,17,4,CC101: Cross covariance of lag1 on PID-BDS,Nucleotide related,#ED7D31
481,17,5,CC103: Cross covariance of lag1 on PID-SKE,Nucleotide related,#ED7D31
482,17,6,AAPH2: Dinucleotide auto covariance of lag2 on APH,Nucleotide related,#ED7D31
483,17,7,AIBA2: Dinucleotide auto covariance of lag2 on IBA,Nucleotide related,#ED7D31
484,17,8,ATIL2: Dinucleotide auto covariance of lag2 on TIL,Nucleotide related,#ED7D31
485,17,9,CC220: Cross covariance of lag2 on SKE-SLI,Nucleotide related,#ED7D31
486,17,10,TraEH: Entropy density H on transcript,Transcript related,#CCB441
487,17,11,SHA: Strong H-Bond acceptors_3120,Hydrogen bond related,#FFC000
488,17,12,PCDAT: Parallel correlation PseDN composition of AT,Nucleotide related,#ED7D31
489,17,13,ORFEH: Entropy density H on ORF,Open reading frame,#BDC6CF
490,17,14,TraAC: Transition between A and C,Transcript related,#CCB441
491,17,15,CNHCA: NH- count composition of A,Molecular fingerprint,#9AB6D1
492,17,16,CNH: NH- count001,Molecular fingerprint,#9AB6D1
493,17,17,TraEQ: Entropy density Q on transcript,Transcript related,#CCB441
494,17,18,ORFEQ: Entropy density Q on ORF,Open reading frame,#BDC6CF
495,17,19,PSN: Primary or secondary nitrogens0,Topological indice,#B4B044
496,17,20,HPC: Gas-hexadecane PC100,Partition coefficient,#C6CEBA
497,17,21,ORFCo: ORF coverage,Open reading frame,#BDC6CF
498,17,22,PHB: Potential Hydrogen Bonds_3201,Hydrogen bond related,#FFC000
499,17,23,HPC: Gas-hexadecane PC_310,Partition coefficient,#C6CEBA
500,17,24,HPCAB: Gas-hexadecane PC_3 transition between A and B,Partition coefficient,#C6CEBA
501,17,25,LFI: Lipoaffinity index_3020,Solubility lipoaffinity,#D1963A
502,17,26,LFI: Lipoaffinity index000,Solubility lipoaffinity,#D1963A
503,17,27,SHA: Strong H-Bond acceptors_3200,Hydrogen bond related,#FFC000
504,18,0,APIA1: Dinucleotide auto covariance of lag1 on PIA,Nucleotide related,#ED7D31
505,18,1,CC117: Cross covariance of lag1 on SKE-BDS,Nucleotide related,#ED7D31
506,18,2,L2WCI: Series correlation PseDN composition of lamda2-WCI,Nucleotide related,#ED7D31
507,18,3,AHCT2: Dinucleotide auto covariance of lag2 on HCT,Nucleotide related,#ED7D31
508,18,4,CC104: Cross covariance of lag1 on PID-WCI,Nucleotide related,#ED7D31
509,18,5,CC116: Cross covariance of lag1 on SKE-PID,Nucleotide related,#ED7D31
510,18,6,AABA1: Dinucleotide auto covariance of lag1 on ABA,Nucleotide related,#ED7D31
511,18,7,AROL2: Dinucleotide auto covariance of lag2 on ROL,Nucleotide related,#ED7D31
512,18,8,ASFB2: Dinucleotide auto covariance of lag2 on SFB,Nucleotide related,#ED7D31
513,18,9,ASHI2: Dinucleotide auto covariance of lag2 on SHI,Nucleotide related,#ED7D31
514,18,10,..,Secondary structure,#76A6D3
515,18,11,SCDAT: Series correlation PseDN composition of AT,Nucleotide related,#ED7D31
516,18,12,ORFET: Entropy density T on ORF,Open reading frame,#BDC6CF
517,18,13,TraET: Entropy density T on transcript,Transcript related,#CCB441
518,18,14,CNH: NH- count00,Molecular fingerprint,#9AB6D1
519,18,15,TPSCA: Topological polar surface area_3 composition of A,Topological indice,#B4B044
520,18,16,CNH: NH- count0,Molecular fingerprint,#9AB6D1
521,18,17,PSNCA: Primary or secondary nitrogens composition of A,Topological indice,#B4B044
522,18,18,SHD: Strong H-Bond donors010,Hydrogen bond related,#FFC000
523,18,19,PSN: Primary or secondary nitrogens00,Topological indice,#B4B044
524,18,20,PSN: Primary or secondary nitrogens000,Topological indice,#B4B044
525,18,21,HPC: Gas-hexadecane PC_3100,Partition coefficient,#C6CEBA
526,18,22,HPC: Gas-hexadecane PC_3001,Partition coefficient,#C6CEBA
527,18,23,HPC: Gas-hexadecane PC_301,Partition coefficient,#C6CEBA
528,18,24,LFIAC: Lipoaffinity index_3 transition between A and C,Solubility lipoaffinity,#D1963A
529,18,25,SHA: Strong H-Bond acceptors_3002,Hydrogen bond related,#FFC000
530,18,26,SHA: Strong H-Bond acceptors_3020,Hydrogen bond related,#FFC000
531,18,27,SHAAC: Strong H-Bond acceptors_3 transition between A and C,Hydrogen bond related,#FFC000
532,19,0,L1ETI: Series correlation PseDN composition of lamda1-ETI,Nucleotide related,#ED7D31
533,19,1,CC119: Cross covariance of lag1 on SKE-WCI,Nucleotide related,#ED7D31
534,19,2,ABDG2: Dinucleotide auto covariance of lag2 on BDG,Nucleotide related,#ED7D31
535,19,3,ADTB2: Dinucleotide auto covariance of lag2 on DTB,Nucleotide related,#ED7D31
536,19,4,CC102: Cross covariance of lag1 on PID-ETI,Nucleotide related,#ED7D31
537,19,5,ABDH2: Dinucleotide auto covariance of lag2 on BDH,Nucleotide related,#ED7D31
538,19,6,ABLS2: Dinucleotide auto covariance of lag2 on BLS,Nucleotide related,#ED7D31
539,19,7,AABA2: Dinucleotide auto covariance of lag2 on ABA,Nucleotide related,#ED7D31
540,19,8,ASHI1: Dinucleotide auto covariance of lag1 on SHI,Nucleotide related,#ED7D31
541,19,9,CC229: Cross covariance of lag2 on SLI-SKE,Nucleotide related,#ED7D31
542,19,10,....,Secondary structure,#76A6D3
543,19,11,...,Secondary structure,#76A6D3
544,19,12,.,Secondary structure,#76A6D3
545,19,13,CNH: NH- count000,Molecular fingerprint,#9AB6D1
546,19,14,TPS: Topological polar surface area_3000,Topological indice,#B4B044
547,19,15,TPS: Topological polar surface area_300,Topological indice,#B4B044
548,19,16,TPS: Topological polar surface area_30,Topological indice,#B4B044
549,19,17,SHDAB: Strong H-Bond donors transition between A and B,Hydrogen bond related,#FFC000
550,19,18,TPS: Topological polar surface area_3020,Topological indice,#B4B044
551,19,19,TPS: Topological polar surface area_3200,Topological indice,#B4B044
552,19,20,FickS: Fickett score,Codon related,#679DC4
553,19,21,SLF: Sum of path lengths starting from oxygens_3010,Topological indice,#B4B044
554,19,22,LFI: Lipoaffinity index_302,Solubility lipoaffinity,#D1963A
555,19,23,SLF: Sum of path lengths starting from oxygens_3020,Topological indice,#B4B044
556,19,24,LFI: Lipoaffinity index_320,Solubility lipoaffinity,#D1963A
557,19,25,LFI: Lipoaffinity index_3200,Solubility lipoaffinity,#D1963A
558,19,26,SHA: Strong H-Bond acceptors_320,Hydrogen bond related,#FFC000
559,19,27,PHBCB: Potential Hydrogen Bonds_3 composition of B,Hydrogen bond related,#FFC000
560,20,0,CC123: Cross covariance of lag1 on WCI-ETI,Nucleotide related,#ED7D31
561,20,1,CC118: Cross covariance of lag1 on SKE-ETI,Nucleotide related,#ED7D31
562,20,2,L2BDS: Series correlation PseDN composition of lamda2-BDS,Nucleotide related,#ED7D31
563,20,3,CC204: Cross covariance of lag2 on PID-WCI,Nucleotide related,#ED7D31
564,20,4,CC121: Cross covariance of lag1 on WCI-PID,Nucleotide related,#ED7D31
565,20,5,CC106: Cross covariance of lag1 on BDS-PID,Nucleotide related,#ED7D31
566,20,6,ASDH2: Dinucleotide auto covariance of lag2 on SDH,Nucleotide related,#ED7D31
567,20,7,ASDS2: Dinucleotide auto covariance of lag2 on SDS,Nucleotide related,#ED7D31
568,20,8,ABDT2: Dinucleotide auto covariance of lag2 on BDT,Nucleotide related,#ED7D31
569,20,9,CC230: Cross covariance of lag2 on SLI-WCI,Nucleotide related,#ED7D31
570,20,10,CC210: Cross covariance of lag2 on BDS-SLI,Nucleotide related,#ED7D31
571,20,11,...(,Secondary structure,#76A6D3
572,20,12,(...,Secondary structure,#76A6D3
573,20,13,.(((,Secondary structure,#76A6D3
574,20,14,(.,Secondary structure,#76A6D3
575,20,15,(.((,Secondary structure,#76A6D3
576,20,16,ORFER: Entropy density R on ORF,Open reading frame,#BDC6CF
577,20,17,SHD: Strong H-Bond donors10,Hydrogen bond related,#FFC000
578,20,18,TPS: Topological polar surface area_320,Topological indice,#B4B044
579,20,19,TPS: Topological polar surface area_3002,Topological indice,#B4B044
580,20,20,SLF: Sum of path lengths starting from oxygens_3001,Topological indice,#B4B044
581,20,21,MLF: Linear free energy101,Hydrogen bond related,#FFC000
582,20,22,SLFCA: Sum of path lengths starting from oxygens_3 composition of A,Topological indice,#B4B044
583,20,23,PHB: Potential Hydrogen Bonds_3102,Hydrogen bond related,#FFC000
584,20,24,SHA: Strong H-Bond acceptors_302,Hydrogen bond related,#FFC000
585,20,25,PHB: Potential Hydrogen Bonds_3101,Hydrogen bond related,#FFC000
586,20,26,HPC: Gas-hexadecane PC101,Partition coefficient,#C6CEBA
587,20,27,ORFEP: Entropy density P on ORF,Open reading frame,#BDC6CF
588,21,0,AWCI1: Dinucleotide auto covariance of lag1 on WCI,Nucleotide related,#ED7D31
589,21,1,ASDG1: Dinucleotide auto covariance of lag1 on SDG,Nucleotide related,#ED7D31
590,21,2,CC109: Cross covariance of lag1 on BDS-WCI,Nucleotide related,#ED7D31
591,21,3,CC202: Cross covariance of lag2 on PID-ETI,Nucleotide related,#ED7D31
592,21,4,CC111: Cross covariance of lag1 on ETI-PID,Nucleotide related,#ED7D31
593,21,5,ADDT1: Dinucleotide auto covariance of lag1 on DDT,Nucleotide related,#ED7D31
594,21,6,ABDT1: Dinucleotide auto covariance of lag1 on BDT,Nucleotide related,#ED7D31
595,21,7,CC115: Cross covariance of lag1 on ETI-SLI,Nucleotide related,#ED7D31
596,21,8,CC125: Cross covariance of lag1 on WCI-SLI,Nucleotide related,#ED7D31
597,21,9,CC228: Cross covariance of lag2 on SLI-ETI,Nucleotide related,#ED7D31
598,21,10,CC225: Cross covariance of lag2 on WCI-SLI,Nucleotide related,#ED7D31
599,21,11,..(,Secondary structure,#76A6D3
600,21,12,..((,Secondary structure,#76A6D3
601,21,13,.((,Secondary structure,#76A6D3
602,21,14,.(,Secondary structure,#76A6D3
603,21,15,((.(,Secondary structure,#76A6D3
604,21,16,SHD: Strong H-Bond donors01,Hydrogen bond related,#FFC000
605,21,17,TPSAC: Topological polar surface area_3 transition between A and C,Topological indice,#B4B044
606,21,18,TraER: Entropy density R on transcript,Transcript related,#CCB441
607,21,19,TPS: Topological polar surface area_302,Topological indice,#B4B044
608,21,20,MLF: Linear free energy1,Hydrogen bond related,#FFC000
609,21,21,MLFCB: Linear free energy composition of B,Hydrogen bond related,#FFC000
610,21,22,SLF: Sum of path lengths starting from oxygens_30,Topological indice,#B4B044
611,21,23,PHB: Potential Hydrogen Bonds_3210,Hydrogen bond related,#FFC000
612,21,24,SLF: Sum of path lengths starting from oxygens_3002,Topological indice,#B4B044
613,21,25,SHA: Strong H-Bond acceptors_3202,Hydrogen bond related,#FFC000
614,21,26,ComRC: Composition of C,Transcript related,#CCB441
615,21,27,HPCCB: Gas-hexadecane PC composition of B,Partition coefficient,#C6CEBA
616,22,0,CC114: Cross covariance of lag1 on ETI-WCI,Nucleotide related,#ED7D31
617,22,1,CC122: Cross covariance of lag1 on WCI-BDS,Nucleotide related,#ED7D31
618,22,2,ABDS1: Dinucleotide auto covariance of lag1 on BDS,Nucleotide related,#ED7D31
619,22,3,CC201: Cross covariance of lag2 on PID-BDS,Nucleotide related,#ED7D31
620,22,4,CC221: Cross covariance of lag2 on WCI-PID,Nucleotide related,#ED7D31
621,22,5,AIBA1: Dinucleotide auto covariance of lag1 on IBA,Nucleotide related,#ED7D31
622,22,6,ASFB1: Dinucleotide auto covariance of lag1 on SFB,Nucleotide related,#ED7D31
623,22,7,CC226: Cross covariance of lag2 on SLI-PID,Nucleotide related,#ED7D31
624,22,8,CC110: Cross covariance of lag1 on BDS-SLI,Nucleotide related,#ED7D31
625,22,9,CC215: Cross covariance of lag2 on ETI-SLI,Nucleotide related,#ED7D31
626,22,10,CC128: Cross covariance of lag1 on SLI-ETI,Nucleotide related,#ED7D31
627,22,11,(..,Secondary structure,#76A6D3
628,22,12,(((.,Secondary structure,#76A6D3
629,22,13,((.,Secondary structure,#76A6D3
630,22,14,(.(,Secondary structure,#76A6D3
631,22,15,.(.,Secondary structure,#76A6D3
632,22,16,SHDCB: Strong H-Bond donors composition of B,Hydrogen bond related,#FFC000
633,22,17,PHB: Potential Hydrogen Bonds_3202,Hydrogen bond related,#FFC000
634,22,18,TPS: Topological polar surface area_3202,Topological indice,#B4B044
635,22,19,SLF: Sum of path lengths starting from oxygens_3100,Topological indice,#B4B044
636,22,20,GCCoW: GC content of whole sequence,Guanine-cytosine related,#9AA983
637,22,21,GCCo3: GC content of 3rd position of codons,Guanine-cytosine related,#9AA983
638,22,22,MLF: Linear free energy110,Hydrogen bond related,#FFC000
639,22,23,PHB: Potential Hydrogen Bonds_3021,Hydrogen bond related,#FFC000
640,22,24,SLF: Sum of path lengths starting from oxygens_3200,Topological indice,#B4B044
641,22,25,SHACC: Strong H-Bond acceptors_3 composition of C,Hydrogen bond related,#FFC000
642,22,26,HPCCB: Gas-hexadecane PC_3 composition of B,Partition coefficient,#C6CEBA
643,22,27,TraEP: Entropy density P on transcript,Transcript related,#CCB441
644,23,0,AETI1: Dinucleotide auto covariance of lag1 on ETI,Nucleotide related,#ED7D31
645,23,1,CC107: Cross covariance of lag1 on BDS-ETI,Nucleotide related,#ED7D31
646,23,2,L1BDS: Series correlation PseDN composition of lamda1-BDS,Nucleotide related,#ED7D31
647,23,3,CC206: Cross covariance of lag2 on BDS-PID,Nucleotide related,#ED7D31
648,23,4,CC211: Cross covariance of lag2 on ETI-PID,Nucleotide related,#ED7D31
649,23,5,AAPH1: Dinucleotide auto covariance of lag1 on APH,Nucleotide related,#ED7D31
650,23,6,CC203: Cross covariance of lag2 on PID-SKE,Nucleotide related,#ED7D31
651,23,7,ASLI1: Dinucleotide auto covariance of lag1 on SLI,Nucleotide related,#ED7D31
652,23,8,CC227: Cross covariance of lag2 on SLI-BDS,Nucleotide related,#ED7D31
653,23,9,CC127: Cross covariance of lag1 on SLI-BDS,Nucleotide related,#ED7D31
654,23,10,CC130: Cross covariance of lag1 on SLI-WCI,Nucleotide related,#ED7D31
655,23,11,((..,Secondary structure,#76A6D3
656,23,12,(..(,Secondary structure,#76A6D3
657,23,13,.((.,Secondary structure,#76A6D3
658,23,14,ORFEG: Entropy density G on ORF,Open reading frame,#BDC6CF
659,23,15,LFICC: Lipoaffinity index_3 composition of C,Solubility lipoaffinity,#D1963A
660,23,16,TPSCC: Topological polar surface area_3 composition of C,Topological indice,#B4B044
661,23,17,PHBCC: Potential Hydrogen Bonds_3 composition of C,Hydrogen bond related,#FFC000
662,23,18,SHD: Strong H-Bond donors101,Hydrogen bond related,#FFC000
663,23,19,LFI: Lipoaffinity index_3202,Solubility lipoaffinity,#D1963A
664,23,20,GCCo2: GC content of 2nd position of codons,Guanine-cytosine related,#9AA983
665,23,21,ORFEA: Entropy density A on ORF,Open reading frame,#BDC6CF
666,23,22,MLF: Linear free energy011,Hydrogen bond related,#FFC000
667,23,23,PHB: Potential Hydrogen Bonds_3012,Hydrogen bond related,#FFC000
668,23,24,HPC: Gas-hexadecane PC_3101,Partition coefficient,#C6CEBA
669,23,25,PHB: Potential Hydrogen Bonds_3011,Hydrogen bond related,#FFC000
670,23,26,PHB: Potential Hydrogen Bonds_3110,Hydrogen bond related,#FFC000
671,23,27,PCDTT: Parallel correlation PseDN composition of TT,Nucleotide related,#ED7D31
672,24,0,ADGC1: Dinucleotide auto covariance of lag1 on DGC,Nucleotide related,#ED7D31
673,24,1,ASMG1: Dinucleotide auto covariance of lag1 on SMG,Nucleotide related,#ED7D31
674,24,2,ASMH1: Dinucleotide auto covariance of lag1 on SMH,Nucleotide related,#ED7D31
675,24,3,ABLS1: Dinucleotide auto covariance of lag1 on BLS,Nucleotide related,#ED7D31
676,24,4,L1PID: Series correlation PseDN composition of lamda1-PID,Nucleotide related,#ED7D31
677,24,5,CC216: Cross covariance of lag2 on SKE-PID,Nucleotide related,#ED7D31
678,24,6,CC205: Cross covariance of lag2 on PID-SLI,Nucleotide related,#ED7D31
679,24,7,CC120: Cross covariance of lag1 on SKE-SLI,Nucleotide related,#ED7D31
680,24,8,ATIL1: Dinucleotide auto covariance of lag1 on TIL,Nucleotide related,#ED7D31
681,24,9,ProII: Pseudo protein instability index,Pseudo protein related,#B3CE93
682,24,10,EiPS2: Electron-ion interaction pseudopotential spectrum 0.5,EIIP based spectrum,#99C94D
683,24,11,L5UTR: Length of 5 untranslated region,Transcript related,#CCB441
684,24,12,SCFFS: Stop codon frequency frame score,Codon related,#679DC4
685,24,13,EipSP: Electron-ion interaction pseudopotential signal peak,EIIP based spectrum,#99C94D
686,24,14,ComRG: Composition of G,Transcript related,#CCB441
687,24,15,TraEG: Entropy density G on transcript,Transcript related,#CCB441
688,24,16,PHB: Potential Hydrogen Bonds_3220,Hydrogen bond related,#FFC000
689,24,17,PHB: Potential Hydrogen Bonds_3022,Hydrogen bond related,#FFC000
690,24,18,TPS: Topological polar surface area_3220,Topological indice,#B4B044
691,24,19,TraEW: Entropy density W on transcript,Transcript related,#CCB441
692,24,20,GCCo1: GC content of 1st position of codons,Guanine-cytosine related,#9AA983
693,24,21,TraEA: Entropy density A on transcript,Transcript related,#CCB441
694,24,22,PHB: Potential Hydrogen Bonds_3120,Hydrogen bond related,#FFC000
695,24,23,SCDCT: Series correlation PseDN composition of CT,Nucleotide related,#ED7D31
696,24,24,PCDCT: Parallel correlation PseDN composition of CT,Nucleotide related,#ED7D31
697,24,25,HPC: Gas-hexadecane PC011,Partition coefficient,#C6CEBA
698,24,26,HPC: Gas-hexadecane PC110,Partition coefficient,#C6CEBA
699,24,27,0,NaN,#000000
700,25,0,APTW1: Dinucleotide auto covariance of lag1 on PTW,Nucleotide related,#ED7D31
701,25,1,CC112: Cross covariance of lag1 on ETI-BDS,Nucleotide related,#ED7D31
702,25,2,ASMS1: Dinucleotide auto covariance of lag1 on SMS,Nucleotide related,#ED7D31
703,25,3,ABDH1: Dinucleotide auto covariance of lag1 on BDH,Nucleotide related,#ED7D31
704,25,4,APID1: Dinucleotide auto covariance of lag1 on PID,Nucleotide related,#ED7D31
705,25,5,ALBZ1: Dinucleotide auto covariance of lag1 on LBZ,Nucleotide related,#ED7D31
706,25,6,ATWI1: Dinucleotide auto covariance of lag1 on TWI,Nucleotide related,#ED7D31
707,25,7,APDT1: Dinucleotide auto covariance of lag1 on PDT,Nucleotide related,#ED7D31
708,25,8,CC129: Cross covariance of lag1 on SLI-SKE,Nucleotide related,#ED7D31
709,25,9,EiPS0: Electron-ion interaction pseudopotential spectrum 0,EIIP based spectrum,#99C94D
710,25,10,EipAP: Electron-ion interaction pseudopotential average power,EIIP based spectrum,#99C94D
711,25,11,EiPS3: Electron-ion interaction pseudopotential spectrum 0.75,EIIP based spectrum,#99C94D
712,25,12,LORFL: Longest ORF length,Open reading frame,#BDC6CF
713,25,13,EiPS4: Electron-ion interaction pseudopotential spectrum 1,EIIP based spectrum,#99C94D
714,25,14,SCCFS: Stop codon count frame score,Codon related,#679DC4
715,25,15,SHD: Strong H-Bond donors011,Hydrogen bond related,#FFC000
716,25,16,SCDCC: Series correlation PseDN composition of CC,Nucleotide related,#ED7D31
717,25,17,SHD: Strong H-Bond donors110,Hydrogen bond related,#FFC000
718,25,18,TPS: Topological polar surface area_3022,Topological indice,#B4B044
719,25,19,GCC2V: GCCo2 variance frame score,Guanine-cytosine related,#9AA983
720,25,20,GCC1V: GCCo1 variance frame score,Guanine-cytosine related,#9AA983
721,25,21,PCDTC: Parallel correlation PseDN composition of TC,Nucleotide related,#ED7D31
722,25,22,SCDTC: Series correlation PseDN composition of TC,Nucleotide related,#ED7D31
723,25,23,SLF: Sum of path lengths starting from oxygens_300,Topological indice,#B4B044
724,25,24,MLF: Linear free energy11,Hydrogen bond related,#FFC000
725,25,25,HPC: Gas-hexadecane PC_3110,Partition coefficient,#C6CEBA
726,25,26,SCDTT: Series correlation PseDN composition of TT,Nucleotide related,#ED7D31
727,25,27,0,NaN,#000000
728,26,0,ADST1: Dinucleotide auto covariance of lag1 on DST,Nucleotide related,#ED7D31
729,26,1,ABDG1: Dinucleotide auto covariance of lag1 on BDG,Nucleotide related,#ED7D31
730,26,2,AHCT1: Dinucleotide auto covariance of lag1 on HCT,Nucleotide related,#ED7D31
731,26,3,ADTB1: Dinucleotide auto covariance of lag1 on DTB,Nucleotide related,#ED7D31
732,26,4,ASEZ1: Dinucleotide auto covariance of lag1 on SEZ,Nucleotide related,#ED7D31
733,26,5,AHTF1: Dinucleotide auto covariance of lag1 on HTF,Nucleotide related,#ED7D31
734,26,6,ARIS1: Dinucleotide auto covariance of lag1 on RIS,Nucleotide related,#ED7D31
735,26,7,L1SLI: Series correlation PseDN composition of lamda1-SLI,Nucleotide related,#ED7D31
736,26,8,SCCou: Stop codon count,Codon related,#679DC4
737,26,9,Base pairs,Secondary structure,#76A6D3
738,26,10,L3UTR: Length of 3 untranslated region,Transcript related,#CCB441
739,26,11,EiPS1: Electron-ion interaction pseudopotential spectrum 0.25,EIIP based spectrum,#99C94D
740,26,12,SCFre: Stop codon frequency,Codon related,#679DC4
741,26,13,TrLen: Transcript length,Transcript related,#CCB441
742,26,14,ProMW: Pseudo protein molecular weight,Pseudo protein related,#B3CE93
743,26,15,EiSNR: Electron-ion interaction pseudopotential signal/noise ratio,EIIP based spectrum,#99C94D
744,26,16,PCDCC: Parallel correlation PseDN composition of CC,Nucleotide related,#ED7D31
745,26,17,LFI: Lipoaffinity index_3220,Solubility lipoaffinity,#D1963A
746,26,18,LFI: Lipoaffinity index_3022,Solubility lipoaffinity,#D1963A
747,26,19,GCC3V: GCCo3 variance frame score,Guanine-cytosine related,#9AA983
748,26,20,PHBBC: Potential Hydrogen Bonds_3 transition between B and C,Hydrogen bond related,#FFC000
749,26,21,TraGC: Transition between G and C,Transcript related,#CCB441
750,26,22,SLF: Sum of path lengths starting from oxygens_3000,Topological indice,#B4B044
751,26,23,MLF: Linear free energy111,Hydrogen bond related,#FFC000
752,26,24,SHA: Strong H-Bond acceptors_3220,Hydrogen bond related,#FFC000
753,26,25,SHA: Strong H-Bond acceptors_3022,Hydrogen bond related,#FFC000
754,26,26,HPC: Gas-hexadecane PC_3011,Partition coefficient,#C6CEBA
755,26,27,0,NaN,#000000
